Chronic Obstructive Pulmonary Disease (COPD) and Advance Directives

Completed

• Conditions: Chronic Obstructive Pulmonary Disease

• Registration Number: NCT04459143
• Lead Sponsor: Hôpital NOVO

Brief Summary

The aim of this study is to evaluate if the participation of COPD patients to a workshop on advance directives increases the number of patients who write them.

Detailed Description

Chronic Obstructive Disease is a common disease and should be the third leading cause of death in 2020. Patient hospitalized for an exacerbation of their COPD have a median survival of 2 years and 50% risk of being rehospitalized within 6 months.

COPD patients may have symptoms that impair their life quality significantly and sometimes more than patients with cancer. This is particularly the case for dyspnea, which is frequently present.

In the study, Investigators propose the setting up of health workshop on advance directives. This workshop is for sever or very severe COPD patients during their hospital stay in the post-acute care and pulmonary rehabilitation service.

In this unit, investigators welcome patient from all the region of Ile de France for a hospital stay of approximately 6 weeks. A first workshop will take place during the third week of their care to inform them about COPD, exacerbations, prognostic and advance directives. Then, a personal interview with patients who have participated to this workshop will take place to collect their advance directives and their degree of satisfaction about this process.

Study Timeline

• Study Start: 2019-05-16
• Study First Submitted: 2020-07-01
• Study First Submitted QC: 2020-07-01
• Study First Posted: 2020-07-07
• Primary Completion: 2020-10-31
• Study Completion: 2020-10-31
• Status Verified: 2021-02
• Last Update Submitted: 2021-02-01
• Last Update Posted: 2021-02-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 525

Inclusion Criteria

• COPD Gold 3 or 4 and Curtis criteria

Exclusion Criteria

• left to the discretion of the investigator if he finds that it will not be beneficial for the patient : for example if the workshop is judged to be at risk of being anxiety-provoking

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of patient who write their advance directives	At the end of patient hospital stay, approximately 6 weeks	The Primary Outcome Measure is the collect of the number of patients who write their advance directives after their participation of the health workshop

Secondary Outcome Measures

Name	Time	Method
Measure of patient's satisfaction	At the end of patient hospital stay, approximately 6 weeks	The satisfaction of patient was measured with a satisfaction questionnaire scale based on their feelings about the workshop. For each item, patient ticks : Strongly agree, Agree, Neither agree or disagree, Disagree or Strongly disagree

Trial Locations

Locations (1)

Les Cèdres SSR Pneumologie / Réhabilitation Respiratoire; 🇫🇷 Aincourt, France